Cargando…

Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study

BACKGROUND: The adjuvant treatment for patients with isolated stromal invasion after radical hysterectomy and pelvic lymph node dissection (PLND) in FIGO stage IB1 and IIA1 cervical carcinoma has not been established. This study assessed the survival outcomes and recurrent patterns in this particula...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lei, Song, XiaoYan, Liu, RuoNan, Li, Nan, Zhang, Ye, Cheng, Yan, Chao, HongTu, Wang, LiYing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936260/
https://www.ncbi.nlm.nih.gov/pubmed/27387204
http://dx.doi.org/10.1186/s12885-016-2447-2
_version_ 1782441537425113088
author Li, Lei
Song, XiaoYan
Liu, RuoNan
Li, Nan
Zhang, Ye
Cheng, Yan
Chao, HongTu
Wang, LiYing
author_facet Li, Lei
Song, XiaoYan
Liu, RuoNan
Li, Nan
Zhang, Ye
Cheng, Yan
Chao, HongTu
Wang, LiYing
author_sort Li, Lei
collection PubMed
description BACKGROUND: The adjuvant treatment for patients with isolated stromal invasion after radical hysterectomy and pelvic lymph node dissection (PLND) in FIGO stage IB1 and IIA1 cervical carcinoma has not been established. This study assessed the survival outcomes and recurrent patterns in this particular group of patients treated with chemotherapy or radiation-based adjuvant therapy. METHODS: The records 133 IB1 and IIA1 postoperative cervical carcinoma patients with histopathology-confirmed isolated deep stromal invasion (DSI) without any other unfavorable pathological finding between June 2010 and March 2013 were analyzed. Sixty-five patients received postoperative adjuvant four to six cycles of cisplatin-based chemotherapy (CT group) and Sixty-eight received postoperative received postoperative adjuvant radiotherapy (RT group). Treatment-related toxicities were evaluated and disease-free survival (DFS) and overall survival (OS) were analyzed using Kaplan-Meier estimates and statistical significance was determined using the log-rank test. RESULTS: With a median follow-up of 33.7 months (range 10–62 months), RT group had a significantly improved in DFS rate (P = 0.044), but there was no significant difference in overall survival (P = 0.437). Upon further analysis, patients with outer 1/3 to full-thickness invasion in chemotherapy group exhibited significantly higher recurrence rates compared to the radiotherapy group. Leukocytopenia, nausea and vomiting were the most frequent short-term complications of chemotherapy, whereas colitis/proctitis and cystitis were more frequent in the radiotherapy group (P = 0.000 respectively). No significant differences were found regards to other acute toxicities, including hemoglobin, platelets and ALT/AST, colitis/proctitis, cystitis and dermatitis (P = 0.000 respectively). Fewer late severe side effects in the chemotherapy group were observed compared with the radiation group and significant differences were found at colitis/proctitis, cystitis and dermatitis (P = 0.000 respectively). CONCLUSION: Compared to chemotherapy alone, postoperative RT to FIGO stages IB1 and IIA1 cervical carcinoma patients with isolated DSI can reduce risk of recurrence and with acceptable morbidity.
format Online
Article
Text
id pubmed-4936260
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49362602016-07-07 Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study Li, Lei Song, XiaoYan Liu, RuoNan Li, Nan Zhang, Ye Cheng, Yan Chao, HongTu Wang, LiYing BMC Cancer Research Article BACKGROUND: The adjuvant treatment for patients with isolated stromal invasion after radical hysterectomy and pelvic lymph node dissection (PLND) in FIGO stage IB1 and IIA1 cervical carcinoma has not been established. This study assessed the survival outcomes and recurrent patterns in this particular group of patients treated with chemotherapy or radiation-based adjuvant therapy. METHODS: The records 133 IB1 and IIA1 postoperative cervical carcinoma patients with histopathology-confirmed isolated deep stromal invasion (DSI) without any other unfavorable pathological finding between June 2010 and March 2013 were analyzed. Sixty-five patients received postoperative adjuvant four to six cycles of cisplatin-based chemotherapy (CT group) and Sixty-eight received postoperative received postoperative adjuvant radiotherapy (RT group). Treatment-related toxicities were evaluated and disease-free survival (DFS) and overall survival (OS) were analyzed using Kaplan-Meier estimates and statistical significance was determined using the log-rank test. RESULTS: With a median follow-up of 33.7 months (range 10–62 months), RT group had a significantly improved in DFS rate (P = 0.044), but there was no significant difference in overall survival (P = 0.437). Upon further analysis, patients with outer 1/3 to full-thickness invasion in chemotherapy group exhibited significantly higher recurrence rates compared to the radiotherapy group. Leukocytopenia, nausea and vomiting were the most frequent short-term complications of chemotherapy, whereas colitis/proctitis and cystitis were more frequent in the radiotherapy group (P = 0.000 respectively). No significant differences were found regards to other acute toxicities, including hemoglobin, platelets and ALT/AST, colitis/proctitis, cystitis and dermatitis (P = 0.000 respectively). Fewer late severe side effects in the chemotherapy group were observed compared with the radiation group and significant differences were found at colitis/proctitis, cystitis and dermatitis (P = 0.000 respectively). CONCLUSION: Compared to chemotherapy alone, postoperative RT to FIGO stages IB1 and IIA1 cervical carcinoma patients with isolated DSI can reduce risk of recurrence and with acceptable morbidity. BioMed Central 2016-07-07 /pmc/articles/PMC4936260/ /pubmed/27387204 http://dx.doi.org/10.1186/s12885-016-2447-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Lei
Song, XiaoYan
Liu, RuoNan
Li, Nan
Zhang, Ye
Cheng, Yan
Chao, HongTu
Wang, LiYing
Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
title Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
title_full Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
title_fullStr Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
title_full_unstemmed Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
title_short Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
title_sort chemotherapy versus radiotherapy for figo stages ib1 and iia1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936260/
https://www.ncbi.nlm.nih.gov/pubmed/27387204
http://dx.doi.org/10.1186/s12885-016-2447-2
work_keys_str_mv AT lilei chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy
AT songxiaoyan chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy
AT liuruonan chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy
AT linan chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy
AT zhangye chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy
AT chengyan chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy
AT chaohongtu chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy
AT wangliying chemotherapyversusradiotherapyforfigostagesib1andiia1cervicalcarcinomapatientswithpostoperativeisolateddeepstromalinvasionaretrospectivestudy